CLINICAL_TRIALS
trial_result
· 2016-01-21
Clinical Trial Update: A Study to Evaluate Safety of Long Term Therapy of Certolizumab Pegol Patients With Crohn's Disease [Phase 3]
Summary
Phase 3 trial evaluating long-term safety of Certolizumab Pegol in Crohn's disease completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: UCB BIOSCIENCES GmbH | Conditions: Crohn Disease | Phase 3 | Status: COMPLETED | Results posted: 2016-01-21